Sort
48,018 grants matching “immunotherapy”
Canine MHC-I genotyping and tumor specific neoantigen determination
$492,039Shaying Zhao · University Of Georgia · R01 · FY2021 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$492,027Thomas G Graeber · University Of California Los Angeles · P01 · FY2024 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$492,026Roger S Lo · University Of California Los Angeles · P01 · FY2024 · CA
Project 3: Modeling and overcoming resistance to melanoma immunotherapy
$492,024Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
$492,000Chen Yao · Ut Southwestern Medical Center · DP2 · FY2024 · AI
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
$492,000Chen Yao · Ut Southwestern Medical Center · DP2 · FY2022 · AI
Deciphering the immunogenicity of cell death using systematic genetic tools
$492,000Roarke Alexander Kamber · University Of California, San Francisco · DP2 · FY2024 · AI
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
$492,000Chen Yao · Ut Southwestern Medical Center · DP2 · FY2023 · AI
Molecular mechanism of natural killer cell recognition
$492,000Jun Huang · University Of Chicago · DP2 · FY2022 · AI
OVERCOMING IMMUNE ESCAPE MECHANISMS IN IMMUNOTHERAPY OF NEUROBLASTOMA
$492,000New York Medical College · · FY2017 · Department of the Army
Harnessing Stem-Like CD8 T Cells for Immunotherapies to Eradicate HIV Reservoirs
$492,000Chen Yao · Ut Southwestern Medical Center · DP2 · FY2025 · AI
Diagnostic Tests and Immunotherapy of Sarcoidosis Using Mycobacterial Proteins
$492,000David R Moller · Johns Hopkins University · P50 · FY2012 · HL
Diagnostic Tests and Immunotherapy of Sarcoidosis Using Mycobacterial Proteins
$492,000David R Moller · Johns Hopkins University · P50 · FY2011 · HL
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
$491,988Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Modulating pathogenic T cells in Type 1 diabetes
$491,898Kevan C Herold · Yale University · R01 · FY2019 · DK
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$491,792Xiongbin Lu · Indiana University Indianapolis · R01 · FY2023 · CA
Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy
$491,739Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Airway Prevotella enhance innate immune-mediated protection against lung infection
$491,669Sarah E Clark · University Of Colorado Denver · R01 · FY2025 · AI
Airway Prevotella enhance innate immune-mediated protection against lung infection
$491,669Sarah E Clark · University Of Colorado Denver · R01 · FY2024 · AI
Airway Prevotella enhance innate immune-mediated protection against lung infection
$491,669Sarah E Clark · University Of Colorado Denver · R01 · FY2023 · AI
Molecular Basis of Parvoviral Target Cell Specificity
$491,659Peter Tattersall · Yale University · R01 · FY2009 · CA
Engineered Vaccines for Neoantigen Targeted Cancer Immunotherapy
$491,618John Tanner Wilson · Vanderbilt University · R01 · FY2025 · CA
Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection
$491,566Michael D Robek · Albany Medical College · R01 · FY2022 · AI
Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection
$491,566Michael D Robek · Albany Medical College · R01 · FY2023 · AI
Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection
$491,566Michael D Robek · Albany Medical College · R01 · FY2024 · AI